This brand name is authorized in Austria, Brazil, Canada, Spain, Finland, Ireland, Malta, Netherlands, New Zealand, Singapore, United Kingdom, South Africa
The drug METVIX contains one active pharmaceutical ingredient (API):
|
1
Methyl aminolevulinate
UNII 7S73606O1A - METHYL AMINOLEVULINATE HYDROCHLORIDE
|
|
Methyl aminolevulinate is a prodrug that is metabolized to protoporphyrin. After topical application of methyl aminolevulinate, porphyrins accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PpIX) are photoactive, fluorescing compounds and, upon light activation in the presence of oxygen, singlet oxygen is formed which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| METVIX Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01XD03 | Methyl aminolevulinate | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XD Sensitizers used in photodynamic/radiation therapy |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510101901177315 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02323273 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 64968 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 085195 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 46502 |
| Country: MT | Medicines Authority | Identifier(s): AA117/01402, AA117/01403 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10204 |
| Country: SG | Health Sciences Authority | Identifier(s): 13410P |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): A38/26/0528 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
